Siheung, South Korea

Jonghwan Park

This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Fine Chemical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonghwan Park. Retrieved from https://idiyas.com/inventor/jonghwan-park-zsvodoqu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jonghwan Park: Innovator in Physiologically Active Polypeptides

Introduction

Jonghwan Park is a notable inventor based in Siheung, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of novel intermediates for physiologically active polypeptides. His work is recognized for its potential applications in various medical and pharmaceutical fields.

Latest Patents

Jonghwan Park holds a patent for a "NOVEL INTERMEDIATE USED FOR PHYSIOLOGICALLY ACTIVE POLYPEPTIDES AND METHOD FOR PREPARING THE SAME." This patent highlights his innovative approach to creating compounds that can have substantial impacts on health and medicine. He has 1 patent to his name, showcasing his dedication to advancing scientific knowledge.

Career Highlights

Currently, Jonghwan Park is employed at Hanmi Fine Chemical Co., Ltd., a company known for its focus on chemical manufacturing and research. His role at the company allows him to further explore his interests in biochemistry and contribute to the development of new chemical products.

Collaborations

Throughout his career, Jonghwan has collaborated with talented individuals such as Wonkyoung Choi and Nari Kim. These partnerships have likely enriched his research and led to innovative solutions in their respective fields.

Conclusion

Jonghwan Park is a dedicated inventor whose work in physiologically active polypeptides is paving the way for advancements in medical science. His contributions are valuable to the ongoing research and development in the chemical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…